华宝中证制药ETF发起联接C(024986) - 基金对比
最后更新于：2026-04-03
非全收益率指数点位的计算不包含分红再投入，所以理论上指数基金的分红再投入收益率高于其对应的指数点位涨幅。
加载中......
| 日期 | 华宝中证制药ETF发起联接C - 相对起始点分红再投入收益率 | 沪深300 - 相对起始点收益率 |
|---|---|---|
| 2026-04-03 | -7.12% | 25.57% |
| 2026-04-02 | -5.68% | 26.65% |
| 2026-04-01 | -6.14% | 27.98% |
| 2026-03-31 | -9.25% | 25.84% |
| 2026-03-30 | -8.50% | 27.02% |
| 2026-03-27 | -9.37% | 27.32% |
| 2026-03-26 | -12.97% | 26.61% |
| 2026-03-25 | -11.78% | 28.31% |
| 2026-03-24 | -12.26% | 26.53% |
| 2026-03-23 | -13.88% | 24.93% |
| 2026-03-20 | -10.46% | 29.14% |
| 2026-03-19 | -9.68% | 29.60% |
| 2026-03-18 | -8.53% | 31.72% |
| 2026-03-17 | -8.97% | 31.13% |
| 2026-03-16 | -9.45% | 32.10% |
| 2026-03-13 | -10.23% | 32.03% |
| 2026-03-12 | -9.78% | 32.55% |
| 2026-03-11 | -9.16% | 33.03% |
| 2026-03-10 | -8.87% | 32.19% |
| 2026-03-09 | -11.09% | 30.51% |
| 2026-03-06 | -10.18% | 31.78% |
| 2026-03-05 | -12.74% | 31.42% |
| 2026-03-04 | -13.44% | 30.15% |
| 2026-03-03 | -12.56% | 31.66% |
| 2026-03-02 | -11.08% | 33.71% |
| 2026-02-27 | -9.44% | 33.20% |
| 2026-02-26 | -9.34% | 33.66% |
| 2026-02-25 | -8.33% | 33.92% |
| 2026-02-24 | -8.91% | 33.12% |
| 2026-02-13 | -8.80% | 31.78% |
| 2026-02-12 | -8.00% | 33.46% |
| 2026-02-11 | -7.32% | 33.29% |
| 2026-02-10 | -7.51% | 33.59% |
| 2026-02-09 | -8.21% | 33.44% |
| 2026-02-06 | -8.54% | 31.31% |
| 2026-02-05 | -8.45% | 32.07% |
| 2026-02-04 | -8.90% | 32.87% |
| 2026-02-03 | -9.87% | 31.78% |
| 2026-02-02 | -10.76% | 30.24% |
| 2026-01-30 | -8.60% | 33.08% |
| 2026-01-29 | -7.57% | 34.43% |
| 2026-01-28 | -8.05% | 33.41% |
| 2026-01-27 | -7.26% | 33.06% |
| 2026-01-26 | -6.48% | 33.10% |
| 2026-01-23 | -6.41% | 32.97% |
| 2026-01-22 | -6.95% | 33.57% |
| 2026-01-21 | -6.10% | 33.56% |
| 2026-01-20 | -5.88% | 33.44% |
| 2026-01-19 | -5.60% | 33.88% |
| 2026-01-16 | -5.27% | 33.80% |